Wednesday, June 24, 2020 10:16:35 PM
Added 50k today, will continue to bid and watch
Recent OTLC News
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution • GlobeNewswire Inc. • 04/21/2026 12:30:00 PM
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • InvestorsHub NewsWire • 04/20/2026 01:00:00 PM
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 01:00:28 PM
- Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress • GlobeNewswire Inc. • 04/16/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 08:31:31 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space • GlobeNewswire Inc. • 04/10/2026 12:30:00 PM
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages • InvestorsHub NewsWire • 04/09/2026 01:00:00 PM
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages • GlobeNewswire Inc. • 04/09/2026 12:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies, • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards • InvestorsHub NewsWire • 04/07/2026 01:19:20 PM
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Shares Rise as Biotech Pivots Toward AI-Driven Pharmaceutical Automation • AllPennyStocks.com • 04/02/2026 05:08:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:15:10 PM
- Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 01:15:35 PM
- Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026 • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios • GlobeNewswire Inc. • 02/23/2026 01:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development • InvestorsHub NewsWire • 02/19/2026 02:00:00 PM

